aT: Acute management by TEVAR (1-14 days from presentation),
sT: Subacute management by TEVAR (15-90 days from presentation)
* Data Median reported, and 22.9% of the cohort lost follow-up in this
study.
|
aT: Acute management by TEVAR (1-14 days from presentation),
sT: Subacute management by TEVAR (15-90 days from presentation)
* Data Median reported, and 22.9% of the cohort lost follow-up in this
study.
|
aT: Acute management by TEVAR (1-14 days from presentation),
sT: Subacute management by TEVAR (15-90 days from presentation)
* Data Median reported, and 22.9% of the cohort lost follow-up in this
study.
|
aT: Acute management by TEVAR (1-14 days from presentation),
sT: Subacute management by TEVAR (15-90 days from presentation)
* Data Median reported, and 22.9% of the cohort lost follow-up in this
study.
|
aT: Acute management by TEVAR (1-14 days from presentation),
sT: Subacute management by TEVAR (15-90 days from presentation)
* Data Median reported, and 22.9% of the cohort lost follow-up in this
study.
|